Literature DB >> 10341205

Tenascin-C modulates tumor stroma and monocyte/macrophage recruitment but not tumor growth or metastasis in a mouse strain with spontaneous mammary cancer.

J F Talts1, G Wirl, M Dictor, W J Muller, R Fässler.   

Abstract

The local growth of tumors and their ability to metastasize are crucially dependent on their interactions with the surrounding extracellular matrix. Tenascin-C (TNC) is an extracellular matrix protein which is highly expressed during development, tissue repair and cancer. Despite the high levels of TNC in the stroma of primary and metastatic tumors, the function of TNC is not known. In the present study we have crossed TNC-null mice with a mouse strain where both female and male mice spontaneously develop mammary tumors followed by metastatic disease in the lungs. We report that the absence of TNC had no effect on the temporal occurrence of mammary tumors and their metastatic dissemination in lungs. Furthermore, the number and size of tumors, the number and size of metastatic foci in the lungs, the proliferation rate and apoptosis of tumor cells and tumor angiogenesis were not altered in the absence of TNC. Histological examination revealed that the tumor organisation, however, was modulated by TNC. In the presence of TNC both primary as well as metastatic tumors were organised in large tumor cell nests surrounded by thick layers of extracellular matrix proteins. In the absence of TNC these tumor cell nests were smaller but still separated from each other by extracellular matrix proteins. In addition, the TNC-null stromal compartment contained significantly more monocytes/macrophages than tumor stroma from TNC wild-type mice. Using in vitro coculture experiments we show that TNC-null tumor cells were still able to activate the TNC gene in fibroblasts which express low basal levels of TNC. Altogether these data indicate that TNC has a very limited role during the spontaneous development and growth of mamary tumors and their metastasis to the lungs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10341205     DOI: 10.1242/jcs.112.12.1855

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  25 in total

1.  Deletion of tenascin-C gene exacerbates atherosclerosis and induces intraplaque hemorrhage in Apo-E-deficient mice.

Authors:  Lai Wang; Wei Wang; Prediman K Shah; Lei Song; Mingjie Yang; Behrooz G Sharifi
Journal:  Cardiovasc Pathol       Date:  2012-02-01       Impact factor: 2.185

Review 2.  Targeting the tumour stroma to improve cancer therapy.

Authors:  Kenneth C Valkenburg; Amber E de Groot; Kenneth J Pienta
Journal:  Nat Rev Clin Oncol       Date:  2018-06       Impact factor: 66.675

3.  Differential expression of micro-heterogeneous LewisX-type glycans in the stem cell compartment of the developing mouse spinal cord.

Authors:  Michael Karus; Eva Hennen; Dina Safina; Alice Klausmeyer; Stefan Wiese; Andreas Faissner
Journal:  Neurochem Res       Date:  2013-04-30       Impact factor: 3.996

4.  Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival.

Authors:  Vasilena Gocheva; Alexandra Naba; Arjun Bhutkar; Talia Guardia; Kathryn M Miller; Carman Man-Chung Li; Talya L Dayton; Francisco J Sanchez-Rivera; Caroline Kim-Kiselak; Noor Jailkhani; Monte M Winslow; Amanda Del Rosario; Richard O Hynes; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-26       Impact factor: 11.205

5.  Bone Marrow-Derived Tenascin-C Attenuates Cardiac Hypertrophy by Controlling Inflammation.

Authors:  Lei Song; Lai Wang; Fuqiang Li; Ada Yukht; Minghui Qin; Haley Ruther; Mingjie Yang; Aurelio Chaux; Prediman K Shah; Behrooz G Sharifi
Journal:  J Am Coll Cardiol       Date:  2017-09-26       Impact factor: 24.094

6.  Regulatory mechanisms that mediate tenascin C-dependent inhibition of oligodendrocyte precursor differentiation.

Authors:  Tim Czopka; Alexander von Holst; Charles ffrench-Constant; Andreas Faissner
Journal:  J Neurosci       Date:  2010-09-15       Impact factor: 6.167

Review 7.  Tenascin-C Signaling in melanoma.

Authors:  Hanshuang Shao; John M Kirkwood; Alan Wells
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

8.  Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis.

Authors:  A Calvo; R Catena; M S Noble; D Carbott; I Gil-Bazo; O Gonzalez-Moreno; J-I Huh; R Sharp; T-H Qiu; M R Anver; G Merlino; R B Dickson; M D Johnson; J E Green
Journal:  Oncogene       Date:  2008-05-26       Impact factor: 9.867

Review 9.  Internal Affairs: Tenascin-C as a Clinically Relevant, Endogenous Driver of Innate Immunity.

Authors:  Anna M Marzeda; Kim S Midwood
Journal:  J Histochem Cytochem       Date:  2018-01-31       Impact factor: 2.479

10.  The role of tenascin-C in tissue injury and tumorigenesis.

Authors:  Kim S Midwood; Gertraud Orend
Journal:  J Cell Commun Signal       Date:  2009-10-17       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.